Ruben et al. confirmed that pleiotropic effects of leptin in breast cancer involved the enhancement of cell proliferation and pro-angiogenic actions linked to leptin-induced expression of cell cycle proteins and regulators in addition to anti-apoptotic and inflammatory factors [26]. The gene discussed is PROS1; the disease is breast cancer.